Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Small Cell Lung Cancer · Metastatic castration-resistant prostate cancer (mCRPC)

Amgen

Amgen patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
One Amgen Center Drive, Thousand Oaks, CA 91320, US HQ
1980 Founded
40,212 Employees
NMPA registrant Type
Company details
Status
Public
HQ
One Amgen Center Drive, Thousand Oaks, CA 91320, US
Founded
1980
Employees
40,212
Programs
96
Drugs
124
Patents
25
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Amgen patents

25 pharmaceutical patents indexed for Amgen. 0 expire within 24 months.

Amgen has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

25 patents

Patent portfolio

  1. WO 2026117667

    DOSES DE TITRATION DE MARIDEBART CAFRAGLUTIDE

    Expires Wed May 30 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2026112486

    MÉTHODES DE TRAITEMENT DE L'OBÉSITÉ ET DES AFFECTIONS LIÉES À L'OBÉSITÉ

    Expires Wed May 23 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2026102199

    THÉRAPIE COMBINÉE D'UN INHIBITEUR DE PRMT5 ET DU DARAXONRASIB POUR UTILISATION DANS LE TRAITEMENT DU CANCER MTAP-NUL

    Expires Thu May 10 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 20260125398

    5,6-FUSED BICYCLIC ALCOHOL COMPOUNDS AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS

    Expires Wed May 02 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 20260116972

    CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

    Expires Wed Apr 25 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2026075950

    SCHÉMA POSOLOGIQUE POUR AGENT ANTI-DLL3

    Expires Wed Apr 04 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. WO 2026072909

    PROTÉINES DE LIAISON À FLT1 ET MÉTHODES D'UTILISATION

    Expires Wed Mar 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2026060304

    ADMINISTRATION SOUS-CUTANÉE D'UN AGENT ANTI-DLL3 POUR LE TRAITEMENT DU CANCER

    Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2026055477

    COMPOSÉS MACROCYCLIQUES CONSTITUANT DES MODULATEURS DE KRAS ET LEURS UTILISATIONS

    Expires Wed Mar 07 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2026039321

    MÉTHODES DE TRAITEMENT DU CANCER DE LA PROSTATE

    Expires Wed Feb 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 20260027049

    AVACOPAN FORMULATIONS

    Expires Wed Jan 24 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2026020076

    MÉTHODE DE TRAITEMENT DU PRURIGO NODULAIRE

    Expires Wed Jan 17 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2026006803

    COMPOSÉS À NOYAU À 5 CHAÎNONS UTILISÉS EN TANT QUE MODULATEURS DE L'HÉLICASE D'ADN RECQ DU SYNDROME DE WERNER ET LEURS UTILISATIONS

    Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. WO 2026006398

    RÉDUCTASES D'IMINE MODIFIÉES ET LEURS PROCÉDÉS D'UTILISATION

    Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. WO 2026006805

    COMPOSÉS À NOYAU À 6 CHAÎNONS UTILISÉS COMME MODULATEURS DE L'HÉLICASE À ADN RECQ DU SYNDROME DE WERNER ET LEURS UTILISATIONS

    Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. WO 2025265110

    COMPOSITIONS PHARMACEUTIQUES ORALES RENFERMANT UN COMPOSÉ DE NAPHTYRIDINE

    Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2025265012

    COMPOSITIONS COMPRENANT DES ANTICORPS ANTI-PCSK9

    Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. WO 2025260042

    CONSTRUCTIONS D'ARNI ET PROCÉDÉS D'INHIBITION DE L'EXPRESSION DE CNR1

    Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. WO 2025259749

    FRAGMENTS VARIABLES À CHAÎNE UNIQUE STABLES

    Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2025259515

    POLYTHÉRAPIE

    Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. WO 2025250569

    TRAITEMENTS DU CANCER UTILISANT DES INHIBITEURS DE PRMT5 MTA-COOPÉRATIFS ET DES INHIBITEURS DE MAT2A

    Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. WO 2025230860

    FORMES SOLIDES DE COMPOSÉS MACROCYCLIQUES ET LEURS UTILISATIONS

    Expires Wed Nov 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. WO 2025230878

    COMPOSÉS MACROCYCLIQUES UTILISÉS EN TANT QUE MODULATEURS DE KRAS ET LEURS UTILISATIONS

    Expires Wed Nov 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. WO 2025230862

    COMPOSÉS AMINÉS MACROCYCLIQUES UTILISÉS EN TANT QUE MODULATEURS DE KRAS ET LEURS UTILISATIONS

    Expires Wed Nov 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 2025333381

    SOLID STATE FORMS

    Expires Wed Oct 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Amgen have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Amgen patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.